Literature DB >> 16706787

T-h-2 immunity and CD3+CD45RBlow-activated T cells in mice immunized with recombinant bacillus Calmette-Guérin expressing HIV-1 principal neutralizing determinant epitope.

Vivekanandhan Aravindhan1, Sujatha Narayanan, Namasivayam Gautham, Vinayaka Prasad, P Kannan, William R Jacobs, Paranjir Narayanan.   

Abstract

The genetic engineering of Mycobacterium bovis-bacillus Calmette-Guérin to express foreign epitopes is an attractive strategy in the field of epitope vaccines. We constructed an 'epitope-trap vector' with Mycobacterium tuberculosis chaperonin-10 as a carrier antigen and used it to express the HIV-1 principal neutralizing determinant epitope. We also identified a new chaperonin-10 promoter that was hyperexpressive compared with the heat shock protein-65 promoter. Splenocytes from recombinant bacillus Calmette-Guérin-immunized mice showed enhanced lymphocyte proliferation and interleukin-4 (but not interferon-gamma) secretion. The recombinant bacillus Calmette-Guérin-immunized group also exhibited mild delayed-type hypersensitivity reaction and a high frequency of CD3+CD45RBlow-activated T cells, together with high titer of antiprincipal neutralizing determinant immunoglobulin G antibodies. Thus, this epitope delivery system induced strong epitope-specific T-h-2 polarization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706787     DOI: 10.1111/j.1574-695X.2006.00061.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  1 in total

1.  BpOmpW Antigen Stimulates the Necessary Protective T-Cell Responses Against Melioidosis.

Authors:  Julen Tomás-Cortázar; Lorenzo Bossi; Conor Quinn; Catherine J Reynolds; David K Butler; Niamh Corcoran; Maitiú Ó Murchú; Eve McMahon; Mahavir Singh; Patpong Rongkard; Juan Anguita; Alfonso Blanco; Susanna J Dunachie; Daniel Altmann; Rosemary J Boyton; Johan Arnold; Severine Giltaire; Siobhán McClean
Journal:  Front Immunol       Date:  2021-12-13       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.